Thomas G Hayhow

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

ACS chemical biology

Journal of medicinal chemistry

Communications biology

Chemistry (Weinheim an der Bergstrasse, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Schade, James S Scott, Thomas G Hayhow, Andy Pike, Ina Terstiege, Marie Ahlqvist, Johan R Johansson, Coura R Diene, Charlene Fallan, Amber Y S Balazs, Elisabetta Chiarparin, David Wilson
Structural and Physicochemical Features of Oral PROTACs. Journal of medicinal chemistry 67 (15) (2024)
Katie L Thomas, Habib Bouguenina, Daniel S J Miller, Fernando J Sialana, Thomas G Hayhow, Jyoti S Choudhary, Olivia W Rossanese, Benjamin R Bellenie
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors. ACS chemical biology 19 (1) (2024)
Katie L Thomas, Habib Bouguenina, Daniel S J Miller, Fernando J Sialana, Thomas G Hayhow, Jyoti S Choudhary, Olivia W Rossanese, Benjamin R Bellenie
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors. ACS chemical biology (2024)
James M Smith, Bernard Barlaam, David Beattie, Lauren Bradshaw, Ho Man Chan, Elisabetta Chiarparin, Olga Collingwood, Sophie L Cooke, Anna Cronin, Iain Cumming, Emma Dean, Judit É Debreczeni, Iván Del Barco Barrantes, Coura R Diene, Davide Gianni, Carine Guerot, Xiaoxiao Guo, Sinem Guven, Thomas G Hayhow, Ted Hong, Paul D Kemmitt, Gillian M Lamont, Scott Lamont, James T Lynch, Lisa McWilliams, Shaun Moore, Piotr Raubo, Graeme R Robb, James Robinson, James S Scott, Bharath Srinivasan, Oliver Steward, Christopher J Stubbs, Karl Syson, Lixiang Tan, Oliver Turner, Elizabeth Underwood, Jelena Urosevic, Mercedes Vazquez-Chantada, Amy L Whittaker, David M Wilson, Jon J Winter-Holt
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity. Journal of medicinal chemistry 67 (16) (2024)
Katie L Thomas, Habib Bouguenina, Daniel S J Miller, Fernando J Sialana, Thomas G Hayhow, Jyoti S Choudhary, Olivia W Rossanese, Benjamin R Bellenie
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors. ACS chemical biology 19 (1) (2024)
Markus Schade, James S Scott, Thomas G Hayhow, Andy Pike, Ina Terstiege, Marie Ahlqvist, Johan R Johansson, Coura R Diene, Charlene Fallan, Amber Y S Balazs, Elisabetta Chiarparin, David Wilson
Structural and Physicochemical Features of Oral PROTACs. Journal of medicinal chemistry 67 (15) (2024)
Thomas G Hayhow, Beth Williamson, Mandy Lawson, Natalie Cureton, Erin L Braybrooke, Andrew Campbell, Rodrigo J Carbajo, Azadeh Cheraghchi-Bashi, Elisabetta Chiarparin, Coura R Diène, Charlene Fallan, David I Fisher, Frederick W Goldberg, Lorna Hopcroft, Philip Hopcroft, Anne Jackson, Jason G Kettle, Teresa Klinowska, Ulrike Künzel, Gillian Lamont, Hilary J Lewis, Gareth Maglennon, Scott Martin, Pablo Morentin Gutierrez, Christopher J Morrow, Myria Nikolaou, J Willem M Nissink, Patrick O'Shea, Radoslaw Polanski, Markus Schade, James S Scott, Aaron Smith, Judith Weber, Joanne Wilson, Bin Yang, Claire Crafter
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC. Communications biology 7 (1) (2024)
Thomas G Hayhow, Beth Williamson, Mandy Lawson, Natalie Cureton, Erin L Braybrooke, Andrew Campbell, Rodrigo J Carbajo, Azadeh Cheraghchi-Bashi, Elisabetta Chiarparin, Coura R Diène, Charlene Fallan, David I Fisher, Frederick W Goldberg, Lorna Hopcroft, Philip Hopcroft, Anne Jackson, Jason G Kettle, Teresa Klinowska, Ulrike Künzel, Gillian Lamont, Hilary J Lewis, Gareth Maglennon, Scott Martin, Pablo Morentin Gutierrez, Christopher J Morrow, Myria Nikolaou, J Willem M Nissink, Patrick O'Shea, Radoslaw Polanski, Markus Schade, James S Scott, Aaron Smith, Judith Weber, Joanne Wilson, Bin Yang, Claire Crafter
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC. Communications biology 7 (1) (2024)
Katie L Thomas, Habib Bouguenina, Daniel S J Miller, Fernando J Sialana, Thomas G Hayhow, Jyoti S Choudhary, Olivia W Rossanese, Benjamin R Bellenie
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors. ACS chemical biology 19 (1) (2024)
Thomas G Hayhow, Beth Williamson, Mandy Lawson, Natalie Cureton, Erin L Braybrooke, Andrew Campbell, Rodrigo J Carbajo, Azadeh Cheraghchi-Bashi, Elisabetta Chiarparin, Coura R Diène, Charlene Fallan, David I Fisher, Frederick W Goldberg, Lorna Hopcroft, Philip Hopcroft, Anne Jackson, Jason G Kettle, Teresa Klinowska, Ulrike Künzel, Gillian Lamont, Hilary J Lewis, Gareth Maglennon, Scott Martin, Pablo Morentin Gutierrez, Christopher J Morrow, Myria Nikolaou, J Willem M Nissink, Patrick O'Shea, Radoslaw Polanski, Markus Schade, James S Scott, Aaron Smith, Judith Weber, Joanne Wilson, Bin Yang, Claire Crafter
Metabolism-driven in vitro/in vivo disconnect of an oral ERɑ VHL-PROTAC. Communications biology 7 (1) (2024)
James M Smith, Bernard Barlaam, David Beattie, Lauren Bradshaw, Ho Man Chan, Elisabetta Chiarparin, Olga Collingwood, Sophie L Cooke, Anna Cronin, Iain Cumming, Emma Dean, Judit É Debreczeni, Iván Del Barco Barrantes, Coura R Diene, Davide Gianni, Carine Guerot, Xiaoxiao Guo, Sinem Guven, Thomas G Hayhow, Ted Hong, Paul D Kemmitt, Gillian M Lamont, Scott Lamont, James T Lynch, Lisa McWilliams, Shaun Moore, Piotr Raubo, Graeme R Robb, James Robinson, James S Scott, Bharath Srinivasan, Oliver Steward, Christopher J Stubbs, Karl Syson, Lixiang Tan, Oliver Turner, Elizabeth Underwood, Jelena Urosevic, Mercedes Vazquez-Chantada, Amy L Whittaker, David M Wilson, Jon J Winter-Holt
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity. Journal of medicinal chemistry 67 (16) (2024)
Katie L Thomas, Habib Bouguenina, Daniel S J Miller, Fernando J Sialana, Thomas G Hayhow, Jyoti S Choudhary, Olivia W Rossanese, Benjamin R Bellenie
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors. ACS chemical biology 19 (1) (2024)
James M Smith, Bernard Barlaam, David Beattie, Lauren Bradshaw, Ho Man Chan, Elisabetta Chiarparin, Olga Collingwood, Sophie L Cooke, Anna Cronin, Iain Cumming, Emma Dean, Judit É Debreczeni, Iván Del Barco Barrantes, Coura R Diene, Davide Gianni, Carine Guerot, Xiaoxiao Guo, Sinem Guven, Thomas G Hayhow, Ted Hong, Paul D Kemmitt, Gillian M Lamont, Scott Lamont, James T Lynch, Lisa McWilliams, Shaun Moore, Piotr Raubo, Graeme R Robb, James Robinson, James S Scott, Bharath Srinivasan, Oliver Steward, Christopher J Stubbs, Karl Syson, Lixiang Tan, Oliver Turner, Elizabeth Underwood, Jelena Urosevic, Mercedes Vazquez-Chantada, Amy L Whittaker, David M Wilson, Jon J Winter-Holt
Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity. Journal of medicinal chemistry (2024)
Markus Schade, James S Scott, Thomas G Hayhow, Andy Pike, Ina Terstiege, Marie Ahlqvist, Johan R Johansson, Coura R Diene, Charlene Fallan, Amber Y S Balazs, Elisabetta Chiarparin, David Wilson
Structural and Physicochemical Features of Oral PROTACs. Journal of medicinal chemistry (2024)
Katie L Thomas, Habib Bouguenina, Daniel S J Miller, Fernando J Sialana, Thomas G Hayhow, Jyoti S Choudhary, Olivia W Rossanese, Benjamin R Bellenie
Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors. ACS chemical biology 19 (1) (2024)
Thomas G Hayhow, Rachel E A Borrows, Coura R Diène, Gary Fairley, Charlene Fallan, Shaun M Fillery, James S Scott, David W Watson
A Buchwald-Hartwig Protocol to Enable Rapid Linker Exploration of Cereblon E3-Ligase PROTACs*. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (70) (2020)

Thomas G Hayhow.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas G Hayhow